The FDA approves AXSM's Symbravo for the acute treatment of migraine with or without aura in adults. The latest nod diversifies its commercial portfolio.
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Sev Melkonian has joined the company as Vice President ...
Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda said it's laser-focused on six pipeline assets that could each reel in ...
Over-the-counter medications can often treat migraine symptoms. However, if your migraine symptoms persist, you may want to talk with a doctor about prescription options. Migraine is a health ...
Medicines can help you manage, prevent, or end headache pain. There are many different treatment options available. Some medicines relieve headache pain, while others target underlying conditions ...
Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 90 percent of adults aged 65 and older take at least one prescription medication, with 66 percent of people in ...
Nerve pain refers to painful sensations around the nerves. Various treatment options are available, including anticonvulsants, certain antidepressants, mild opioids, and some topical treatments.
LUMRYZ was approved by the FDA on May 1, 2023, as the first and only once-at-bedtime treatment for cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. The approval was supported ...